Smith, Hannah M.
Moodie, Joanna E.
Monterrubio-Gómez, Karla
Gadd, Danni A.
Hillary, Robert F.
Chybowska, Aleksandra D.
McCartney, Daniel L.
Campbell, Archie
Redmond, Paul
Page, Danielle
Taylor, Adele
Corley, Janie
Harris, Sarah E.
Valdés Hernández, Maria
Muñoz Maniega, Susana
Bastin, Mark E.
Wardlaw, Joanna M.
Deary, Ian J.
Boardman, James P.
Mullin, Donncha S.
Russ, Tom C.
Cox, Simon R.
Marioni, Riccardo E.
Article History
Received: 30 November 2023
Accepted: 16 March 2024
First Online: 25 March 2024
Declarations
:
: All components of GS received ethical approval from the NHS Tayside Committee on Medical Research Ethics (REC Reference Number: 05/S1401/89). GS has also been granted Research Tissue Bank status by the East of Scotland Research Ethics Service (REC Reference Number: 20-ES-0021), providing generic ethical approval for a wide range of uses within medical research. Ethics permission for the Lothian Birth Cohort 1936 (LBC1936) was obtained from the Multi-Centre Research Ethics Committee for Scotland (Wave 1: MREC/01/0/56), the Lothian Research Ethics Committee (Wave 1: LREC/2003/2/29), and the Scotland A Research Ethics Committee (Waves 2, 3, 4 & 5: 07/MRE00/58). Ethics permission for the Lothian Birth Cohort 1921 (LBC1921) was obtained from the Lothian Research Ethics Committee (Wave 1: LREC/1998/4/183; Wave 2: LREC/2003/7/23; Wave 3: LREC1702/98/4/183) and the Scotland A Research Ethics Committee (Wave 4: 10/S1103/6; Wave 5: 10/MRE00/87).
: Not applicable.
: R.E.M is an advisor to the Epigenetic Clock Development Foundation, and Optima partners. R.F.H. has received consultant fees from Illumina and Optima partners. D.A.G. has received consultant fees from, and is currently employed in part-time capacity, by Optima Partners. D.L.McC. and is currently employed in part-time capacity, by Optima Partners. All other authors declare no competing interest.